Pages that link to "Q30951913"

The following pages link to Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins (Q30951913):

Displaying 26 items.

• Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade (Q28288148) ‎ (← links)
• A phage display screen and binding studies with acetylated low density lipoprotein provide evidence for the importance of the scavenger receptor cysteine-rich (SRCR) domain in the ligand-binding function of MARCO. (Q33235835) ‎ (← links)
• Exercise-induced up-regulation of MMP-1 and IL-8 genes in endurance horses (Q33474167) ‎ (← links)
• Integrins as "functional hubs" in the regulation of pathological angiogenesis (Q33591910) ‎ (← links)
• Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. (Q33723927) ‎ (← links)
• Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer (Q33757096) ‎ (← links)
• Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells (Q34028202) ‎ (← links)
• Natural selection in a bangladeshi population from the cholera-endemic ganges river delta (Q34355363) ‎ (← links)
• Localizing matrix metalloproteinase activities in the pericellular environment (Q34418625) ‎ (← links)
• Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway (Q34778175) ‎ (← links)
• Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells (Q35221967) ‎ (← links)
• A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells. (Q36201708) ‎ (← links)
• Peripheral membrane associations of matrix metalloproteinases (Q36356192) ‎ (← links)
• alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen. (Q36402945) ‎ (← links)
• Integrin antagonists as therapeutics for inflammatory diseases (Q36600298) ‎ (← links)
• Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs (Q36652550) ‎ (← links)
• Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization (Q36715904) ‎ (← links)
• Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles (Q36868727) ‎ (← links)
• Regulation of integrin activity and signalling (Q37324659) ‎ (← links)
• Role of leukemia cell invadosome in extramedullary infiltration (Q37373047) ‎ (← links)
• Matrix metalloproteinase-2 as a target for head and neck cancer therapy (Q38068476) ‎ (← links)
• The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. (Q38336225) ‎ (← links)
• Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. (Q40559840) ‎ (← links)
• Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases (Q47155746) ‎ (← links)
• Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions. (Q47748198) ‎ (← links)
• Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces (Q90282610) ‎ (← links)